Summary & Overview
CPT 87250: Viral Isolation in Embryonated Egg or Small Animal
CPT code 87250 represents a specialized virology laboratory procedure for isolating viruses by inoculating embryonated eggs or small animals and observing viral growth, including dissection when needed. This code is significant nationally because it captures diagnostic and research activities that support infectious disease identification, outbreak response, and public health surveillance. It is used by hospital and commercial laboratories, public health agencies, and reference laboratories when culture-based isolation is required.
Key payers commonly involved in coverage for this service include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find context on the clinical purpose of the procedure, typical settings where it is performed, and the role this service plays in diagnostic workflows. The publication summarizes billing and coding considerations, common modifiers used with lab services, and related clinical implications for laboratory operations. It also highlights national relevance for surveillance and specialty diagnostic pathways. Data not available in the input will be noted where applicable, including payer-specific reimbursement rates and procedure volume benchmarks.
Billing Code Overview
CPT code 87250 describes a laboratory procedure in which a lab analyst isolates a virus by inoculating a developing embryo in an egg or a small animal, allowing the virus to grow, and observing for signs of viral growth, which may include dissection for direct observation. This service is a viral isolation procedure used to obtain live virus for identification and characterization.
-
Service type: Viral isolation and culture using embryonated eggs or small animals
-
Typical site of service: Clinical or public health laboratories, research laboratories, and specialized diagnostic virology facilities
Clinical & Coding Specifications
Clinical Context
A mid-40s patient presents to a hospital infectious disease laboratory after a clinician suspects a viral etiology for an acute febrile respiratory illness that has not yielded a definitive diagnosis by rapid antigen testing and molecular assays. A respiratory specimen (nasopharyngeal swab or aspirate) or tissue sample is delivered to the virology lab. The virology technologist inoculates the specimen into embryonated eggs or a susceptible small animal model to attempt viral isolation. The sample is incubated and observed over several days for cytopathic effects, embryonic death, or other signs of viral growth; dissection and direct observation may be performed to identify characteristic lesions. Results are used to confirm viable virus, enable further typing, culture-based susceptibility testing, or preparation of isolates for public health reference laboratories.
Typical site of service: Hospital clinical virology laboratory, public health laboratory, or specialized research/diagnostic laboratory with biosafety facilities.
Typical patient scenario: A patient hospitalized with pneumonia and worsening hypoxia after negative initial PCR panels, where isolation is pursued to detect unusual or culture-requiring pathogens (for example, certain influenza strains, orthomyxoviruses, or other agents requiring culture for characterization). The laboratory documents specimen accession, inoculation, incubation, observation, and any dissection performed as part of the isolation process.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 |